Opioid Detox Protocols and Medications

Opioid detox is the medically supervised process of managing withdrawal symptoms when someone dependent on opioids, whether prescription painkillers, heroin, or fentanyl, stops using. While opioid withdrawal is rarely life-threatening on its own, the intense physical discomfort drives most people to resume use before withdrawal resolves. Medication-assisted detox using buprenorphine (Suboxone), clonidine, or methadone tapering protocols significantly increases the likelihood that patients complete withdrawal and transition to ongoing treatment. ASAM guidelines recommend medication-assisted approaches as the standard of care for opioid withdrawal management.

Key Takeaways

• Opioid withdrawal produces severe flu-like symptoms including pain, nausea, diarrhea, and anxiety, but is rarely medically dangerous
• Buprenorphine (Suboxone) is the most widely used medication for opioid detox, reducing withdrawal severity and supporting transition to MAT
• Short-acting opioid withdrawal (heroin, fentanyl) typically peaks at 36-72 hours; long-acting opioid withdrawal (methadone) peaks at 72-96 hours
• Home detox from opioids carries significant relapse risk due to loss of tolerance and lack of medical support
• Opioid detox should transition into medication-assisted treatment or comprehensive rehab, not end with withdrawal completion

How Opioid Detox Works

The Clinical Protocol

Opioid detox follows a structured clinical process designed to manage withdrawal safely and prepare the patient for ongoing treatment:

1. Assessment: Clinicians evaluate the type and amount of opioids used, duration of use, last use timing, medical history, co-occurring conditions, and prior treatment episodes. The Clinical Opiate Withdrawal Scale (COWS) provides a standardized severity rating.

2. Medication induction: Once withdrawal symptoms reach a sufficient severity (typically a COWS score of 8 or higher), medication is initiated. For buprenorphine-based protocols, premature induction, before withdrawal has begun, can trigger precipitated withdrawal, a sudden intensification of symptoms.

3. Stabilization: Medication dosing is adjusted over 1-3 days to manage symptoms effectively. Supportive medications address specific symptoms like insomnia, nausea, and diarrhea.

4. Tapering or maintenance: Depending on the treatment plan, the detox medication may be tapered over several days to weeks, or the patient may transition directly into ongoing medication-assisted treatment (MAT) at a maintenance dose.

5. Transition to treatment: The clinical team coordinates transfer to residential rehab, outpatient programming, or an ongoing MAT provider.

ASAM Guidelines for Opioid Withdrawal

The American Society of Addiction Medicine published updated practice guidelines recommending:

• Medication-assisted approaches as the standard for opioid withdrawal management
• Buprenorphine or methadone tapering as preferred over clonidine-only protocols for comfort and completion rates
• Continuing medication-assisted treatment beyond the acute withdrawal period whenever clinically appropriate, as evidence consistently shows that ongoing MAT reduces relapse and overdose mortality
• Integration of psychosocial support alongside medication during detox

These guidelines reflect decades of research demonstrating that medication-assisted approaches produce better outcomes than abstinence-based detox protocols for opioid use disorder.

Medications Used in Opioid Detox

Buprenorphine (Suboxone)

Buprenorphine: A partial opioid agonist that binds to opioid receptors in the brain, reducing withdrawal symptoms and cravings without producing the full euphoric effect of drugs like heroin or fentanyl. It is most commonly prescribed as Suboxone, a combination of buprenorphine and naloxone.

Buprenorphine is the most widely used medication for opioid detox because it:

• Significantly reduces withdrawal symptom severity
• Can be started once moderate withdrawal begins (COWS score of 8+)
• Has a ceiling effect that limits respiratory depression risk
• Can transition seamlessly from detox dosing to ongoing MAT maintenance
• Can be prescribed in office-based settings, expanding access beyond specialized clinics

Induction protocol: Buprenorphine induction typically begins 12-24 hours after the last use of short-acting opioids, or 24-48 hours after long-acting opioids. The initial dose is generally 2-4 mg, with additional doses given every 2-4 hours as needed, up to a total first-day dose of 8-16 mg. Dosing is adjusted over subsequent days.

In New Jersey, buprenorphine can be prescribed by any physician, nurse practitioner, or physician assistant with a standard DEA license, following the elimination of the federal X-waiver requirement.

Clonidine and Supportive Medications

Clonidine: An alpha-2 adrenergic agonist originally developed for blood pressure management. In opioid detox, clonidine reduces the autonomic symptoms of withdrawal: sweating, anxiety, agitation, muscle aches, and runny nose. It does not address cravings or the subjective experience of withdrawal as effectively as buprenorphine.

Clonidine-based protocols are sometimes used when:

• Buprenorphine or methadone are contraindicated
• The patient declines medication-assisted treatment
• As an adjunct to buprenorphine for residual symptoms

Additional supportive medications commonly used during opioid detox:

• Loperamide (Imodium): For diarrhea
• Ondansetron (Zofran): For nausea and vomiting
• Hydroxyzine or trazodone: For anxiety and insomnia
• Ibuprofen or acetaminophen: For muscle aches and pain
• Dicyclomine: For abdominal cramping

Methadone Tapering

Methadone is a full opioid agonist used in both detox and maintenance treatment for opioid use disorder. In a detox context, methadone is administered at a stabilizing dose and then gradually tapered over days to weeks.

Methadone tapering for detox typically occurs in licensed Opioid Treatment Programs (OTPs) because methadone for opioid use disorder can only be dispensed through these federally regulated facilities. In New Jersey, OTPs are located across the state and accept NJ FamilyCare (Medicaid), private insurance, and self-pay.

Methadone tapering is sometimes preferred for:

• Patients dependent on high-dose or long-acting opioids
• Patients who have not responded well to buprenorphine
• Institutional settings (hospitals, correctional facilities) with OTP capability

Opioid Detox Timeline

Short-Acting Opioids (Heroin, Fentanyl)

For heroin, fentanyl, oxycodone (immediate-release), and hydrocodone:

• 8-24 hours after last use: Onset of withdrawal. Early symptoms include anxiety, agitation, muscle aches, increased tearing, runny nose, and sweating.
• 36-72 hours: Peak withdrawal. Symptoms intensify to include severe abdominal cramping, diarrhea, nausea and vomiting, dilated pupils, goosebumps, and intense cravings.
• 5-7 days: Gradual resolution. Acute physical symptoms diminish over the course of the first week, though fatigue, insomnia, and mood disturbance may persist.

Fentanyl withdrawal can be more unpredictable than heroin withdrawal due to the drug’s lipophilic properties and variable elimination from body tissues. Some patients experience prolonged or delayed withdrawal symptoms with fentanyl.

Long-Acting Opioids (Methadone, OxyContin)

For methadone and extended-release opioid formulations:

• 24-48 hours after last dose: Delayed onset compared to short-acting opioids. Early symptoms are similar but appear later.
• 72-96 hours: Peak withdrawal. Symptom severity is often comparable to short-acting opioid withdrawal but the time course is extended.
• 10-21 days: Extended resolution. Methadone withdrawal, in particular, can produce withdrawal symptoms lasting two to three weeks or longer, making it one of the more protracted opioid withdrawal syndromes.

Post-acute withdrawal syndrome (PAWS) may follow the acute phase, producing persistent low-grade symptoms including sleep disturbance, anxiety, irritability, and cravings that can last weeks to months.

Why Home Detox from Opioids Is Risky

Attempting opioid detox at home, without medical supervision, carries significant risks:

• Relapse during withdrawal: The intensity of opioid withdrawal drives most unsupervised detox attempts to end in resumed use. Without medication to manage symptoms, the discomfort becomes overwhelming for many individuals.
• Loss of tolerance: Even a few days of abstinence significantly reduces opioid tolerance. If someone resumes use after partial withdrawal at the same dose they previously used, the risk of fatal overdose is substantially elevated.
• No medication access: Buprenorphine and methadone require prescriptions and clinical supervision for safe induction. Over-the-counter remedies do not adequately manage moderate-to-severe opioid withdrawal.
• Dehydration and medical complications: Severe vomiting and diarrhea without medical monitoring can lead to dangerous dehydration and electrolyte imbalances.
• No transition plan: Home detox typically lacks a bridge to ongoing treatment, leaving the individual vulnerable to relapse once the immediate withdrawal resolves.

ASAM and SAMHSA both recommend against unsupervised opioid withdrawal and advocate for medically managed detox followed by continued treatment.

Transitioning from Detox to Treatment

Completing opioid detox is a critical first step, but it is not treatment for opioid use disorder. The transition from detox to ongoing care is where long-term outcomes are determined.

Recommended pathways following opioid detox:

• Continuation of MAT: The strongest evidence supports continuing buprenorphine or transitioning to injectable naltrexone (Vivitrol) after detox completion. Research published by NIDA demonstrates that ongoing MAT reduces opioid-related mortality and improves treatment retention. For a comprehensive overview, see our guide to medication-assisted treatment.
• Residential treatment: For patients with severe opioid use disorder, co-occurring conditions, or unstable living environments, inpatient rehab provides intensive therapeutic support during early recovery.
• Outpatient treatment: IOP or standard outpatient programming combined with MAT provides structured support while allowing patients to maintain daily responsibilities.
• Peer support and recovery services: Connection with recovery community organizations, peer recovery specialists, and mutual-aid groups reinforces treatment gains.

The goal of opioid detox is not simply to stop using. It is to create a safe, stable medical foundation from which the longer work of recovery can begin. For an overview of medical detox across all substance types, and to understand how detox differs from rehab, see Medical Detox vs. Social Detox vs. Rehab.

---

This is part of our complete guide to Types of Addiction Treatment.